Today, at the IPMG Stakeholders’ Forum, we proudly launched the IPMG Manifesto—a strategic roadmap to transform access to medical innovation in Indonesia.
Recently, IPMG joined a meeting between the Head of BADAN PENGAWAS OBAT DAN MAKANAN, Prof. dr. Taruna Ikrar, M.Biomed., Ph.D and Japan Pharmaceutical Manufacturers Association (JPMA), where we witnessed his passion and determination to elevate Badan POM to WHO Listed Authority (WLA) status. This ambitious vision has been a consistent focus for Prof. Ikrar, who reiterated his commitment during the meeting and warmly invited JPMA to share ideas or initiatives to support BPOM in achieving this goal within the next year.
Congratulations Bayer Indonesia, one of IPMG member companies, to have reinforced its commitment to Indonesia's climate goals by inaugurating the country's largest rooftop solar power system in the multinational pharmaceutical sector at its Cimanggis plant, Depok, West Java. Utilizing 3,770 photovoltaic modules, this solar power installation generates 2,054 kWp, will eliminate carbon emissions by 2,073 metric tons annually, equivalent to planting 95,000 trees or removing 450 cars from the road.
The pharmaceutical industry, particularly in Indonesia, faces several challenges. The first is that 95% of raw materials for medicines are still imported, placing a financial burden on producers—exacerbated by fluctuations in the Rupiah's exchange rate against foreign currencies.
Jakarta, 12 Desember 2024 – International Pharmaceutical Manufacturers Group (IPMG), yang mewakili perusahaan riset biofarmasi global terkemuka di Indonesia, hari ini mengadakan Forum Diskusi Pemangku Kepentingan untuk pertama kalinya
Jakarta, 13 November 2024 – The International Pharmaceutical Manufacturers Group (IPMG), an association representing leading research-based multinational biopharmaceutical companies operating in Indonesia, today issued a call to action to develop a national strategy that can strengthen Indonesia's health system and drive economic growth through expanded access to innovative medicines
Jakarta, — The International Pharmaceutical Manufacturers Group (IPMG), representing over 27 leading research-based pharmaceutical companies committed to advancing healthcare in Indonesia